99 related articles for article (PubMed ID: 4333494)
1. The clinical pharmacology of 5-trifluoromethyl-2'-deoxyuridine.
Dexter DL; Wolberg WH; Ansfield FJ; Helson L; Heidelberger C
Cancer Res; 1972 Feb; 32(2):247-53. PubMed ID: 4333494
[No Abstract] [Full Text] [Related]
2. Distribution and excretion of cyclocytidine in monkeys, dogs, and rats.
Hirayama H; Sugihara T; Hamada F; Kanai T; Hikita J
Gan; 1974 Apr; 65(2):153-61. PubMed ID: 4209835
[No Abstract] [Full Text] [Related]
3. Mechanism of action of showdomycin. V. Reduced ability of showdomycin-resistant mutants of Escherichia coli K-12 to take up showdomycin and nucleosides.
Komatsu Y
J Antibiot (Tokyo); 1971 Dec; 24(12):876-83. PubMed ID: 4946509
[No Abstract] [Full Text] [Related]
4. Clinical pharmacology of 1-beta-d-arabinofuranosyl cytosine.
Ho DH; Frei E
Clin Pharmacol Ther; 1971; 12(6):944-54. PubMed ID: 5289712
[No Abstract] [Full Text] [Related]
5. Purine and pyrimidine excretion in Hodgkin's disease.
Pinkard KJ; Cooper IA; Motteram R; Turner CN
J Natl Cancer Inst; 1972 Jul; 49(1):27-38. PubMed ID: 5037436
[No Abstract] [Full Text] [Related]
6. Clinical and pharmacological studies with 5-hydroxy-2-formylpyridine thiosemicarbazone.
DeConti RC; Toftness BR; Agrawal KC; Tomchick R; Mead JA; Bertino JR; Sartorelli AC; Creasey WA
Cancer Res; 1972 Jul; 32(7):1455-62. PubMed ID: 4555384
[No Abstract] [Full Text] [Related]
7. Metabolism of uracil and 5-fluorouracil in P388 murine leukemia cells.
Kessel D; Hall TC; Reyes P
Mol Pharmacol; 1969 Sep; 5(5):481-6. PubMed ID: 5388697
[No Abstract] [Full Text] [Related]
8. The metabolism of pyrimidine compounds by Tetrahymena pyriformis.
Wykes JR; Prescott DM
J Cell Physiol; 1968 Dec; 72(3):173-84. PubMed ID: 5724568
[No Abstract] [Full Text] [Related]
9. Urinary pyrimidines after x-irradiation.
Guri CD; Cole LJ
Clin Chem; 1968 May; 14(5):383-90. PubMed ID: 5649972
[No Abstract] [Full Text] [Related]
10. Use of novel beta-L(-)-nucleoside analogues for treatment and prevention of chronic hepatitis B virus infection and hepatocellular carcinoma.
Bridges EG; Cheng YC
Prog Liver Dis; 1995; 13():231-45. PubMed ID: 9224504
[No Abstract] [Full Text] [Related]
11. Metabolism of 1-beta-D-arabinofuranosylcytosine in leukemia L1210: studies with intact cells.
Shrecker AW; Urshel MJ
Cancer Res; 1968 Apr; 28(4):793-801. PubMed ID: 5649066
[No Abstract] [Full Text] [Related]
12. Pharmacodynamics of co-administration of uracil and 1-(2-tetrahydrofuryl)-5-fluorouracil (FT-207) for malignant brain tumors.
Harada K; Okamoto H; Fujioka Y; Kiya K; Uozumi T
Hiroshima J Med Sci; 1983 Dec; 32(4):443-9. PubMed ID: 6432742
[No Abstract] [Full Text] [Related]
13. FLUORINATED PYRIMIDINES. XXIV. IN VIVO METABOLISM OF 5-TRIFLUOROMETHYLURACIL-2-C-14 AND 5-TRIFLUOROMETHYL-2'-DEOXYURIDINE-2-C-14.
HEIDELBERGER C; BOOHAR J; KAMPSCHROER B
Cancer Res; 1965 Apr; 25():377-81. PubMed ID: 14281103
[No Abstract] [Full Text] [Related]
14. Rates of formation of blood-borne uridine and cytidine in dogs.
Tseng J; Barelkovski J; Gurpide E
Am J Physiol; 1971 Sep; 221(3):869-78. PubMed ID: 5570345
[No Abstract] [Full Text] [Related]
15. [On the excretion of coproporphyrin isomers I and 3 in liver and blood ailments].
Clotten R; Doyen A
Z Klin Chem Klin Biochem; 1967 Mar; 5(2):54-9. PubMed ID: 5304174
[No Abstract] [Full Text] [Related]
16. Distribution and excretion studies of procarbazine in animals and man.
Schwartz DE; Bollag W; Obrecht P
Arzneimittelforschung; 1967 Nov; 17(11):1389-93. PubMed ID: 5632152
[No Abstract] [Full Text] [Related]
17. The metabolic degradation of methoxyflurane in man.
Holaday DA; Rudofsky S; Treuhaft PS
Anesthesiology; 1970 Dec; 33(6):589-93. PubMed ID: 5477642
[No Abstract] [Full Text] [Related]
18. A phase II study of tegafur plus uracil or tegafur alone for the treatment of advanced hepatocellular carcinoma.
Zavaglia C; Prisco C; Pinzello G
Eur J Gastroenterol Hepatol; 2008 Jan; 20(1):87-8. PubMed ID: 18090998
[No Abstract] [Full Text] [Related]
19. Stimulatory effects of inosine and deoxyinosine on the incorporation of uracil-2-14-C, 5-fluorouracil-2-14-C, and 5-bromouracil-2-14-C into nucleic acids by Ehrlich ascites tumor cells in vitro.
Gotto AM; Belkhode ML; Touster O
Cancer Res; 1969 Apr; 29(4):807-11. PubMed ID: 5775710
[No Abstract] [Full Text] [Related]
20. Pharmacokinetic study of intralesional cisplatin for the treatment of hepatocellular carcinoma.
Mok TS; Kanekal S; Lin XR; Leung TW; Chan AT; Yeo W; Yu S; Chak K; Leavitt R; Johnson P
Cancer; 2001 Jun; 91(12):2369-77. PubMed ID: 11413527
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
